You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway

 

Online download statistics by month:

Online download statistics by month: March 2022 to August 2025

AbstractFullPdf
Mar 2022653683357
Apr 2022357388193
May 2022304311117
Jun 2022262274113
Jul 202226927891
Aug 202226727478
Sep 2022251263103
Oct 202221221780
Nov 202217017572
Dec 202217718267
Jan 202317917990
Feb 2023177182130
Mar 2023169173123
Apr 202312112380
May 202310911071
Jun 202312212269
Jul 202310811156
Aug 202313613765
Sep 20239910162
Oct 202314715186
Nov 202320520964
Dec 202320320760
Jan 2024939452
Feb 202416516993
Mar 2024168168119
Apr 2024156157113
May 2024121124132
Jun 202411912160
Jul 202410310354
Aug 2024848198
Sep 202410510584
Oct 2024909056
Nov 202410511082
Dec 202411511939
Jan 2025175175108
Feb 2025179179133
Mar 2025129130106
Apr 2025155156113
May 202510710881
Jun 2025798067
Jul 2025110
Aug 2025110
Total694771213817